Medicare Enrolled
Dr. Naveen Sikka, M.D.
Internal Medicine · Frisco, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sikka from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sikka?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sikka
Dr. Naveen Sikka is an internal medicine specialist in Frisco, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sikka performed 35,174 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sikka received a total of $95,218 from 47 pharmaceutical and/or device companies across 728 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sikka is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 1% volume in TX
$95,218 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗35,174
Medicare services
Top 1% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tezepelumab injection, 1 mg An injection of tezepelumab-ekko, a medication administered in 1 mg doses. |
25,410 | $14 | $37 |
| Omalizumab injection (Xolair) for asthma/allergy | 3,945 | $30 | $81 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
2,089 | $3 | $18 |
| Allergy immunotherapy preparation A professional service involving the preparation and administration of one or more antigens. |
940 | $11 | $35 |
| Skin allergy test A test where small amounts of potential allergens are injected into the skin to check for allergic reactions. |
821 | $6 | $27 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
500 | $9 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
334 | $11 | $89 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
289 | $92 | $321 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
193 | $15 | $152 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
116 | $47 | $286 |
| Allergy test using drug or biological combination A diagnostic procedure to identify allergic reactions by testing a combination of methods using a specific drug or biological agent. |
87 | $15 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $65 | $206 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
77 | $14 | $44 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
54 | $20 | $105 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
45 | $6 | $8 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $113 | $360 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
39 | $3 | $80 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
27 | $29 | $172 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $130 | $474 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
20 | $51 | $174 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
16 | $7 | $44 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
16 | $0 | $19 |
| Inhaled albuterol and ipratropium bromide via DME Administration of FDA-approved albuterol and ipratropium bromide medication through durable medical equipment. |
12 | $0 | $12 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.9% high complexity
86.0% medium
13.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$95,218
Total received (2018-2024)
Avg $13,603/year across 7 years
Top 2% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
728
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$17,721
2023
$34,043
2022
$18,475
2021
$13,102
2020
$6,642
2019
$3,904
2018
$1,331
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$12,806
GlaxoSmithKline, LLC.
$3,048
Amgen Inc.
$524
Takeda Pharmaceuticals U.S.A., Inc.
$371
Regeneron Healthcare Solutions, Inc.
$236
BioCryst US Sales Co., LLC
$163
SUN PHARMACEUTICAL INDUSTRIES INC.
$122
Novartis Pharmaceuticals Corporation
$100
Octapharma USA, Inc.
$71
PFIZER INC.
$45
Grifols USA, LLC
$44
Blueprint Medicines Corporation
$33
Genentech USA, Inc.
$30
CSL Behring
$29
GENZYME CORPORATION
$25
Kyowa Kirin, Inc.
$22
Galderma Laboratories, L.P.
$19
TG Therapeutics, Inc.
$18
Hikma Pharmaceuticals USA
$14
Top 3 companies account for 92.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$62,171
AstraZeneca Pharmaceuticals LP
$14,963
Genentech USA, Inc.
$5,187
GENZYME CORPORATION
$2,943
Amgen Inc.
$2,004
Regeneron Healthcare Solutions, Inc.
$1,368
Takeda Pharmaceuticals U.S.A., Inc.
$1,099
BioCryst US Sales Co., LLC
$595
Teva Pharmaceuticals USA, Inc.
$547
PFIZER INC.
$472
Novartis Pharmaceuticals Corporation
$466
Octapharma USA, Inc.
$407
Grifols USA, LLC
$403
Shire North American Group Inc
$369
CSL Behring
$326
ALK-Abello, Inc
$266
Aimmune Therapeutics, Inc.
$201
Covis Pharma GmBH
$182
Pharming Healthcare, Inc.
$155
Boehringer Ingelheim Pharmaceuticals, Inc.
$123
SUN PHARMACEUTICAL INDUSTRIES INC.
$122
Covis Pharma GmbH
$96
kaleo, Inc.
$90
Optinose US, Inc.
$88
OptiNose US, Inc.
$68
BioCryst Pharmaceuticals, Inc.
$40
Philips Electronics North America Corporation
$39
Regeneron Pharmaceuticals, Inc.
$38
Covis Pharma B.V.
$37
Blueprint Medicines Corporation
$33
Horizon Therapeutics plc
$28
Xoran Technologies
$27
Merck Sharp & Dohme LLC
$23
TerSera Therapeutics LLC
$23
Kyowa Kirin, Inc.
$22
AIMMUNE THERAPEUTICS, INC.
$20
Pharmacyclics LLC, an AbbVie Company
$20
Galderma Laboratories, L.P.
$19
Sun Pharmaceutical Industries Inc.
$18
TG Therapeutics, Inc.
$18
Incyte Corporation
$17
Circassia Pharmaceuticals Inc
$16
Acerta Pharma LLC
$15
Greer Laboratories, Inc.
$15
Hikma Pharmaceuticals USA
$14
Phadia US Inc.
$14
Mylan Specialty L.P.
$12
Top 3 companies account for 86.5% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ALVESCO · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · ArmonAir Digihaler · BREO · BREZTRI · BREZTRI AEROSPHERE · BRIUMVI · CEREZYME · CIBINQO · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · Crysvita · DEXILANT · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FASENRA · FIRAZYR · Gamunex-C · HYQVIA · Haegarda · Hizentra · ILUMYA · IMBRUVICA · ImmunoCAP · Kcentra · MiniCAT · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORALAIR · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · ProAir Digihaler · Prolastin-C Liquid · QVAR · Quzyttir · RUCONEST · Respiratoriy Care Undiv · Ryaltris · SAPHNELO · SPIRIVA RESPIMAT · STANDARDIZED · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEPEZZA · TEZSPIRE · TIMOTHY · TRELEGY ELLIPTA · TUDORZA PRESSAIR · VPRIV · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
1,541
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT & WHITE MEDICAL CENTER - CENTENNIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sikka is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sikka experienced with tezepelumab injection, 1 mg?
Based on Medicare claims data, Dr. Sikka performed 25,410 tezepelumab injection, 1 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sikka receive payments from pharmaceutical companies?
Yes. Dr. Sikka received a total of $95,218 from 47 companies across 728 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sikka's costs compare to other internal medicine physicians in Frisco?
Dr. Sikka's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sikka) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Frisco
Browse internal medicine physicians in Frisco ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology